Itron SVP Reeves sells 519 shares under 10b5-1

Itron, Inc. senior vice president of Outcomes Donald L. Reeves III reported selling a total of 519 shares of Itron common stock in open-market transactions.

Rhea-AI Filing Summary

Itron, Inc. senior vice president of Outcomes Donald L. Reeves III reported selling a total of 519 shares of Itron common stock in open-market transactions. The sales occurred on February 25, 2026 at a price of $97.84 per share under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. After these trades, Reeves directly holds 29,951 shares of Itron common stock.

Insider Trade Summary

Net Seller: 519 shares

Net Sell 2 txns

Insider Reeves Donald L. III

Role SVP, Outcomes

Sold 519 shs ($51K)

Type	Security	Shares	Price	Value
Sale	Common Stock	220	$97.84	$22K
Sale	Common Stock	299	$97.84	$29K

Holdings After Transaction: Common Stock — 29,951 shares (Direct)

Footnotes (1)

1. F1. Represents number of shares sold under a Rule 10b5-1 Trading Plan adopted by Mr. Reeves on September 11, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Itron (ITRI) report for Donald L. Reeves III?

Itron reported that Donald L. Reeves III sold 519 shares of common stock. The shares were sold in open-market transactions at $97.84 per share, and the activity was disclosed in a Form 4 insider trading report.

At what price did Donald L. Reeves III sell Itron (ITRI) shares?

Donald L. Reeves III sold Itron common stock at $97.84 per share. The Form 4 shows two open-market sale transactions on February 25, 2026, both executed at this same per-share price.

How many Itron (ITRI) shares does Donald L. Reeves III hold after the sale?

After the reported transactions, Donald L. Reeves III directly holds 29,951 Itron common shares. This post-transaction balance reflects the net position following the sale of 519 shares on February 25, 2026.

Was the Itron (ITRI) insider sale by Donald L. Reeves III under a 10b5-1 plan?

Yes. The Form 4 footnote states the 519 shares sold were under a Rule 10b5-1 trading plan. That plan was adopted by Donald L. Reeves III on September 11, 2025, before the February 2026 transactions.

What role does Donald L. Reeves III hold at Itron (ITRI)?

Donald L. Reeves III serves as senior vice president, Outcomes at Itron. His officer status is disclosed in the Form 4, which identifies him as an executive officer rather than a director or 10% beneficial owner.

How many Itron (ITRI) insider sale transactions were reported for February 25, 2026?

The filing lists two non-derivative sale transactions in Itron common stock on February 25, 2026. Both are coded as open-market sales, totaling 519 shares sold at a price of $97.84 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 11:47 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reeves Donald L. III

(Last) (First) (Middle)

2111 N. MOLTER ROAD

(Street)

LIBERTY LAKE WA 99019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ITRON, INC. [ ITRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Outcomes

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		S		220(1)	D	$97.84	30,250	D
Common Stock	02/25/2026		S		299(1)	D	$97.84	29,951	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents number of shares sold under a Rule 10b5-1 Trading Plan adopted by Mr. Reeves on September 11, 2025.

	/s/ Christopher E. Ware, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.